Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorGungor, Ozkan
dc.contributor.authorDheir, Hamad
dc.contributor.authorIslam, Mahmud
dc.contributor.authorToz, Huseyin
dc.contributor.authorYildiz, Abdulmecit
dc.contributor.authorSinangil, Ayse
dc.contributor.authorTatar, Erhan
dc.date.accessioned2025-01-12T18:54:42Z
dc.date.available2025-01-12T18:54:42Z
dc.date.issued2024
dc.identifier.issn0301-0430
dc.identifier.urihttps://doi.org/10.5414/CN111300
dc.identifier.urihttp://hdl.handle.net/11446/4951
dc.description.abstractAim: BK polyomavirus infection is a challenging complication of renal transplantation. The management is not standardized and is based on reports from transplantation centers' experiences, usually with small sample sizes. Therefore, we aimed to present our countrywide experience with BK virus nephropathy (BKVN) in renal transplant recipients. Materials and methods: Our study was carried out with the participation of 30 transplantation centers from all regions of Turkey. Only cases with allograft biopsy-proven BKVN were included in the study. Results: 13,857 patients from 30 transplantation centers were screened, and 207 BK nephropathy cases were included. The mean age was 46.4 +/- 13.1 years, and 146 (70.5%) patients were male. The mean time to diagnosis of BK nephropathy was 15.8 +/- 22.2 months after transplantation. At diagnosis, the mean creatinine level was 1.8 +/- 0.7 mg/dL, and the mean estimated glomerular filtration rate was 45.8 +/- 19.6 mL/min/1.73m2. 2 . In addition to dose reduction or discontinuation of immunosuppressive drugs, 18 patients were treated with cidofovir, 11 patients with leflunomide, 17 patients with quinolones, 15 patients with intravenous immunoglobulin (IVIG), 5 patients with cidofovir plus IVIG, and 12 patients with leflunomide plus IVIG. None of the patients receiving leflunomide or leflunomide plus IVIG had allograft loss. During follow-up, allograft loss occurred in 32 (15%) out of 207 patients with BK nephropathy. Conclusion: BKVN is still a frequent cause of allograft loss in kidney transplantation and is not fully elucidated. The results of our study suggest that leflunomide treatment is associated with more favorable allograft outcomes.en_US
dc.description.sponsorshipOrgan transplant is teamwork. There-fore, we would like to thank the transplant surgeons, pathologists, microbiologists, and interventional radiologists for their efforts in diagnosing and treating the patients we included in the study.en_US
dc.language.isoengen_US
dc.publisherDustri-Verlag Dr Karl Feistleen_US
dc.relation.ispartofClinical Nephrologyen_US
dc.identifier.doi10.5414/CN111300
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBK virus nephropathyen_US
dc.subjectgraft dysfunctionen_US
dc.subjectgraft Lossen_US
dc.subjectkidney biopsyen_US
dc.subjectkidney transplantationen_US
dc.subjectPolyomavirus Infectionen_US
dc.subjectManagementen_US
dc.subjectImpacten_US
dc.titleBiopsy-proven BK virus nephropathy in renal transplant recipients: A multi-central study from Turkey (BK-TURK STUDY)en_US
dc.typearticleen_US
dc.departmentDBÜen_US
dc.identifier.issue4en_US
dc.identifier.volume102en_US
dc.identifier.startpage202en_US
dc.identifier.endpage211en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-temp[Gungor, Ozkan; Altunoren, Orcun; Guzel, Fatma Betul] Kahramanmaras Sutcu Imam Univ, Fac Med, Div Nephrol, Kahramanmaras, Turkiye; [Dheir, Hamad; Islam, Mahmud] Sakarya Univ, Fac Med, Div Nephrol, Sakarya, Turkiye; [Toz, Huseyin; Asci, Gulay] Ege Univ, Fac Med, Div Nephrol, Izmir, Turkiye; [Yildiz, Abdulmecit; Ersoy, Alparslan] Uludag Univ, Fac Med, Div Nephrol, Bursa, Turkiye; [Sinangil, Ayse] Demiroglu Bilim Univ, Florence Nightingale Hosp, Fac Med, Div Nephrol, Istanbul, Turkiye; [Tatar, Erhan] Univ Hlth Sci, Izmir Bozyaka Educ & Res Hosp, Fac Med, Div Nephrol, Izmir, Turkiye; [Ulutas, Ozkan] Inonu Univ, Fac Med, Div Nephrol, Malatya, Turkiye; [Altun, Eda; Apaydin, Suheyla] Bahcesehir Univ, Med Pk Goztepe Hosp, Fac Med, Div Nephrol, Istanbul, Turkiye; [Korucu, Berfu; Derici, Ulver; Yildirim, Saliha] Gazi Univ, Fac Med, Div Nephrol, Ankara, Turkiye; [Safak, Seda; Turkmen, Aydin] Istanbul Univ, Fac Med, Div Nephrol, Istanbul, Turkiye; [Seyahi, Nurhan; Ozcan, Seyda Gul] Istanbul Cerrahpasa Univ, Fac Med, Div Nephrol, Istanbul, Turkiye; [Atilgan, Kadir Gokhan; Ayli, Mehmet Deniz] Univ Hlth Sci, Diskapi Yildirim Beyazit Training & Res Hosp, Fac Med, Div Nephrol, Ankara, Turkiye; [Cavdar, Caner; Uzun, Ozcan] Dokuz Eylul Univ, Fac Meden_US
dc.identifier.pmid39037084en_US
dc.identifier.scopus2-s2.0-85205021979en_US
dc.identifier.wosWOS:001277471800001en_US
dc.authorwosidÖzer, Hakan/HKN-9433-2023
dc.authorwosidislam, Mahmud/HHS-1422-2022
dc.authorwosidŞafak, Seda/AAY-9982-2020
dc.authorwosidİnci, Ayça/E-5325-2016
dc.authorwosidKorucu, Berfu/J-9988-2019
dc.authorwosidKAYA, BULENT/GQA-5126-2022
dc.authorwosidcebeci, egemen/S-7661-2016
dc.authorscopusid8906634000
dc.authorscopusid37088045900
dc.authorscopusid57220973674
dc.authorscopusid6603879983
dc.authorscopusid56256977500
dc.authorscopusid55324055500
dc.authorscopusid37038668300


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster